{"id":"https://openalex.org/W4393073229","doi":"https://doi.org/10.1158/1538-7445.am2024-1968","title":"Abstract 1968: Discovery of a highly potent and selective FGFR2 inhibitor for FGFR2-driven cancers","display_name":"Abstract 1968: Discovery of a highly potent and selective FGFR2 inhibitor for FGFR2-driven cancers","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393073229","doi":"https://doi.org/10.1158/1538-7445.am2024-1968"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-1968","doi":"https://doi.org/10.1158/1538-7445.am2024-1968","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-1968","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100639481","display_name":"Wenqian Li","orcid":"https://orcid.org/0000-0002-1000-2689","observed_orcids":["https://orcid.org/0000-0002-1000-2689"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wenqian Li","raw_affiliation_strings":["1Acerand Therapeutics US, Carmel, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Acerand Therapeutics US, Carmel, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Bin Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bin Liu","raw_affiliation_strings":["1Acerand Therapeutics US, Carmel, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Acerand Therapeutics US, Carmel, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100643054","display_name":"Junmei Wang","orcid":"https://orcid.org/0000-0002-9607-8229","observed_orcids":["https://orcid.org/0000-0002-9607-8229","https://orcid.org/0000-0002-8336-9457","https://orcid.org/0000-0002-9502-4851"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Junmei Wang","raw_affiliation_strings":["1Acerand Therapeutics US, Carmel, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Acerand Therapeutics US, Carmel, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104262808","display_name":"Tinggui Yin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tinggui Yin","raw_affiliation_strings":["1Acerand Therapeutics US, Carmel, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Acerand Therapeutics US, Carmel, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102076843","display_name":"Kuo\u2010Long Yu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kuo-Long Yu","raw_affiliation_strings":["1Acerand Therapeutics US, Carmel, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Acerand Therapeutics US, Carmel, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043150287","display_name":"Sanjeev Kumar","orcid":"https://orcid.org/0000-0003-0692-3925","observed_orcids":["https://orcid.org/0000-0003-0692-3925","https://orcid.org/0000-0002-7375-7341"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sanjeev Kumar","raw_affiliation_strings":["1Acerand Therapeutics US, Carmel, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Acerand Therapeutics US, Carmel, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Zhiming Wen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhiming Wen","raw_affiliation_strings":["1Acerand Therapeutics US, Carmel, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Acerand Therapeutics US, Carmel, IN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110387482","display_name":"Genshi Zhao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Genshi Zhao","raw_affiliation_strings":["1Acerand Therapeutics US, Carmel, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Acerand Therapeutics US, Carmel, IN","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101321717","display_name":"Weitao Pan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Weitao Pan","raw_affiliation_strings":["1Acerand Therapeutics US, Carmel, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Acerand Therapeutics US, Carmel, IN","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"1968","last_page":"1968"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fgfr2-fusion","display_name":"FGFR2 fusion","score":0.8119999766349792},{"id":"https://openalex.org/keywords/fgfr2-amplification","display_name":"FGFR2 amplification","score":0.972000002861023},{"id":"https://openalex.org/keywords/fgfr2-mutations","display_name":"FGFR2 mutations","score":0.9200000166893005},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.847000002861023},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.7540000081062317},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9539999961853027},{"id":"https://openalex.org/keywords/endometrial-cancer","display_name":"endometrial cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.6510000228881836},{"id":"https://openalex.org/keywords/fulvestrant","display_name":"fulvestrant","score":0.9539999961853027},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4134272038936615},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41256090998649597},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.36658909916877747},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3642752170562744},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33325695991516113},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32757842540740967}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-1968","doi":"https://doi.org/10.1158/1538-7445.am2024-1968","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-1968","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4282927683","https://openalex.org/W4307911269","https://openalex.org/W1969012061","https://openalex.org/W4409625284","https://openalex.org/W4379364374","https://openalex.org/W4379983690","https://openalex.org/W4396640952","https://openalex.org/W2138272238","https://openalex.org/W3178164610","https://openalex.org/W7172305825"],"abstract_inverted_index":{"Abstract":[0],"Fibroblast":[1],"growth":[2],"factor":[3],"receptor":[4],"2":[5],"(FGFR2)":[6],"is":[7,203,352],"a":[8,77,103,175,204,234,278,296,301,353,366,401],"clinically":[9,272],"validated":[10],"target":[11],"and":[12,63,100,118,126,137,153,194,206,219,227,254,268,293,300,345,355,404],"frequently":[13],"altered":[14],"in":[15,128,144,174,250,295,319,343,346],"many":[16],"solid":[17,27],"tumors.":[18,28],"The":[19],"resulting":[20],"oncogenic":[21,376],"driver":[22,275,377],"alterations":[23,164,276],"often":[24],"drive":[25],"multiple":[26,145,372],"Therefore,":[29],"targeting":[30],"FGFR2":[31,79,106,113,150,208,260,274,307,357,375,406],"has":[32,71],"broad":[33,236],"therapeutic":[34],"potential.":[35],"Currently,":[36],"only":[37],"pan-FGFR":[38,69],"inhibitors":[39,70],"are":[40,326],"approved":[41],"for":[42,48,90,371,408,418],"FGFR2-driven":[43,50,409],"intrahepatic":[44],"cholangiocarcinoma,":[45],"but":[46,155,191],"not":[47,156,192,313],"other":[49,124],"cancers.":[51],"Due":[52],"to":[53,362],"the":[54,65,68,82,87,98,186,213,258,322,330,360,415],"severe":[55],"on-target":[56],"toxicity":[57],"associated":[58],"with":[59,241,277,291,359],"inhibition":[60],"of":[61,67,102,177,238,400,414],"FGFR1":[62,125],"FGFR4,":[64],"use":[66],"been":[72],"very":[73],"limited.":[74,94],"Thus,":[75,201],"developing":[76],"selective":[78,105,207,356,405],"inhibitor":[80,358,407],"addresses":[81],"unmet":[83],"medical":[84],"need":[85],"as":[86],"treatment":[88,369],"options":[89],"FGFR2-altered":[91],"cancers":[92,270,373,410],"remain":[93],"Here":[95],"we":[96],"report":[97],"discovery":[99],"characterization":[101],"highly":[104,402],"inhibitor,":[107],"ACE-16229210.":[108],"This":[109,231,282],"molecule":[110,232,283],"potently":[111,133],"inhibits":[112,140],"(IC50":[114,134,165],"=":[115],"6.2":[116],"nM)":[117,136],"exhibits":[119,212],"excellent":[120,336],"selectivity":[121,337],"(>133-fold)":[122],"over":[123,338],"FGFR4":[127,162,198],"biochemical":[129],"assays.":[130],"It":[131],"also":[132,284],"<1":[135],"selectively":[138],"(\u2265500-fold)":[139],"FGFR2-induced":[141],"ERK":[142],"phosphorylation":[143],"cancer":[146,303],"cell":[147,179,187],"lines":[148,188],"harboring":[149,158,189,271,306,374],"fusions,":[151,225],"amplification,":[152,226,308],"mutations,":[154],"those":[157],"FGFR1,":[159,196],"FGFR3,":[160,193],"or":[161,197],"genetic":[163,199],">":[166],"460":[167],"nM).":[168],"Furthermore,":[169],"this":[170],"molecule,":[171],"when":[172,289],"evaluated":[173],"panel":[176],"24":[178],"lines,":[180],"demonstrates":[181,285],"potent":[182,205,215,354,403],"anti-proliferative":[183],"activity":[184,216,240],"against":[185,217],"FGFR2,":[190],"especially":[195],"alterations.":[200,378],"ACE-16229210":[202,311,351],"inhibitor.":[209],"Interestingly,":[210],"it":[211],"most":[214],"gatekeeper":[218],"molecular":[220],"brake":[221],"mutations":[222],"followed":[223],"by":[224],"activation":[228],"loop":[229],"mutations.":[230],"shows":[233],"robust":[235],"spectrum":[237],"antitumor":[239],"significant":[242],"tumor":[243,252,262,298],"regression":[244],"at":[245,321],"low":[246],"doses":[247],"(1-10":[248],"mg/kg)":[249],"several":[251],"xenograft":[253],"PDX":[255,304],"models":[256],"representing":[257],"major":[259],"relevant":[261],"histologies":[263],"including":[264],"gastric,":[265],"breast,":[266],"ovarian,":[267],"endometrial":[269],"important":[273],"well-defined":[279],"pharmacokinetic/pharmacodynamic":[280],"relationship.":[281],"strong":[286],"synergistic":[287],"effects":[288],"combined":[290],"irinotecan":[292],"fulvestrant":[294],"gastric":[297],"model":[299,305],"breast":[302],"respectively.":[309],"Finally,":[310],"did":[312],"significantly":[314],"affect":[315],"serum":[316],"phosphorus":[317],"levels":[318,324],"animals":[320],"exposure":[323],"that":[325,350],">100-fold":[327],"higher":[328],"than":[329],"efficacious":[331],"AUC,":[332],"further":[333],"confirming":[334],"its":[335],"FGFR1.":[339],"Taken":[340],"together,":[341],"these":[342],"vitro":[344],"vivo":[347],"studies":[348],"show":[349],"potential":[361],"be":[363],"developed":[364],"into":[365],"more":[367],"effective":[368],"option":[370],"Citation":[379],"Format:":[380],"Wenqian":[381],"Li,":[382],"Bin":[383],"Liu,":[384],"Junmei":[385],"Wang,":[386],"Tinggui":[387],"Yin,":[388],"Kuo-Long":[389],"Yu,":[390],"Sanjeev":[391],"Kumar,":[392],"Zhiming":[393],"Wen,":[394],"Genshi":[395],"Zhao,":[396],"Weitao":[397],"Pan.":[398],"Discovery":[399],"[abstract].":[411],"In:":[412],"Proceedings":[413],"American":[416],"Association":[417],"Cancer":[419,437],"Research":[420],"Annual":[421],"Meeting":[422],"2024;":[423],"Part":[424],"1":[425],"(Regular":[426],"Abstracts);":[427],"2024":[428],"Apr":[429],"5-10;":[430],"San":[431],"Diego,":[432],"CA.":[433],"Philadelphia":[434],"(PA):":[435],"AACR;":[436],"Res":[438],"2024;84(6_Suppl):Abstract":[439],"nr":[440],"1968.":[441]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2024-03-23T00:00:00"}